Biotage AB - Company Profile
Powered by 
All the data and insights you need on Biotage AB in one report.
$295
- Save hours of research time and resources with
our up-to-date Biotage AB Strategy Report
- Understand Biotage AB position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Biotage AB (Biotage) is a life science company that provides separation and synthesis technologies. It offers medicinal and analytical chemistry, peptide synthesis, organic synthesis, separation and chromatography and purification solutions. The company’s major products and service areas include sample preparation products, work-up products, evaporation, and concentration, industrial and large- scale products, horizon food and environmental products, biomolecules Service and support, peptide chemistry, oligo synthesis, and flash purification. Biotage serves solutions to academic institutions, government authorities, pharmaceutical, biotech and food companies. It has operations in China, Japan, South Korea, India, UK, and the US. Biotage is headquartered in Uppsala, Sweden.
Headquarters
Sweden
Address
Vimpelgatan 5, Uppsala, 75318
Website
www.biotage.com
Telephone
46 18 565900
No of Employees
674
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
BIOT (STO)
Revenue (2022)
$175.5M
18.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-8.2%
(2022 vs 2021)
Market Cap*
$1.2B
Net Profit Margin (2022)
XYZ
-22.8%
(2022 vs 2021)
* As of and is in US$
Biotage AB premium industry data and analytics
Products and Services
| Products |
|---|
| High Performance Filtration Plates |
| Protein Precipitation Plates |
| SPE Columns and Plates |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In December, the company entered into a partnership with Gyros Protein Technologies AB to offer offer Biotage PeptiPEC on the Biotage Extrahera system. |
| 2023 | Acquisitions/Mergers/Takeovers | In June, the company acquired Astrea Bioseparations from Gamma Biosciences. |
| 2022 | New Products/Services | In May, the company announce the launch of Biotage Selekt Enkel, a new addition to the Biotage family of flash purification systems. |
Competitor Comparison
| Key Parameters | Biotage AB | Johnson Matthey Plc | Agilent Technologies Inc | Waters Corp | Anton Paar GmbH |
|---|---|---|---|---|---|
| Headquarters | Sweden | United Kingdom | United States of America | United States of America | Austria |
| City | Uppsala | London | Santa Clara | Milford | Graz |
| State/Province | - | England | California | Massachusetts | Steiermark |
| No. of Employees | 674 | 12,666 | 17,700 | 7,900 | 3,500 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Torben Jorgensen | Chairman | Executive Board | 2020 | 71 |
| Tomas Blomquist | President; Chief Executive Officer | Senior Management | 2019 | 53 |
| Andrew Kellett | Chief Financial Officer | Senior Management | 2024 | - |
| Lars Backman | Chief Legal Officer | Senior Management | 2020 | 62 |
| Olof Nord | Executive Vice President - Business Development | Executive Board | 2020 | 48 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward